跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,556 条关于
“Bioeq AG”
全部
1,556
临床试验
356
药物
384
机构
288
资讯
528
去年
Bio Usawa and Bioeq AG Partner to Bring Ranibizumab Biosimilar to Sub-Saharan Africa
去年
Formycon Halts Phase III Trial of FYB206 Following FDA Feedback, Faces Market Challenges for Biosimilars
11个月前
Europe's First Ranibizumab Biosimilar Pre-filled Syringe Launches in France
11个月前
Rwanda FDA Approves First Biosimilar Ranibizumab in Africa for Sight-Threatening Eye Diseases
去年
Formycon's Ranivisio Becomes First Lucentis Biosimilar Approved in Brazil
去年
Formycon's FYB206, a Keytruda Biosimilar, Enters Clinical Development Amidst Strong Financial Results
去年
Bio Usawa and ServareGMP Partner to Establish Monoclonal Antibody Manufacturing in Africa
6个月前
Formycon AG Secures €650M Biosimilar Partnership with ATHOS KG in Landmark Deal
去年
Fabhalta Demonstrates Sustained Efficacy in Phase III C3 Glomerulopathy Trial
去年
Formycon's Aflibercept Biosimilar, AHZANTIVE®/Baiama®, Receives Positive CHMP Opinion for EU Approval
第 1 页,共 53 页
上一页
下一页